BlackRock Amends COLLEGIUM PHARMACEUTICAL Stake (SC 13G/A)
Ticker: COLL · Form: SC 13G/A · Filed: Jan 19, 2024 · CIK: 1267565
| Field | Detail |
|---|---|
| Company | Collegium Pharmaceutical, Inc (COLL) |
| Form Type | SC 13G/A |
| Filed Date | Jan 19, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in COLLEGIUM PHARMACEUTICAL as of year-end 2023.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 19, 2024, indicating its ownership of Common Stock in COLLEGIUM PHARMACEUTICAL, INC. as of December 31, 2023. This filing, Amendment No. 7, updates BlackRock's passive investment stake in the pharmaceutical company. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in confidence or strategy regarding COLLEGIUM PHARMACEUTICAL, INC.'s future performance.
Why It Matters
This filing shows BlackRock's updated ownership in COLLEGIUM PHARMACEUTICAL, INC., providing transparency on a significant institutional investor's position, which can influence market perception.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note BlackRock's continued passive stake in COLLEGIUM PHARMACEUTICAL, INC. and monitor future filings for any significant changes in ownership percentage, which could signal a shift in BlackRock's investment thesis.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- COLLEGIUM PHARMACEUTICAL, INC. (company) — the subject company whose shares are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 19, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 7 (number) — the specific amendment number of the filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'Amendment No: 7'.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., as stated under the 'FILED BY' section.
What is the subject company of this filing?
The subject company is COLLEGIUM PHARMACEUTICAL, INC., as identified under the 'SUBJECT COMPANY' section and 'Name of Issuer'.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as specified in the document.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' next to '[X] Rule 13d-1(b)'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 19, 2024 regarding COLLEGIUM PHARMACEUTICAL, INC (COLL).